跳到正文
原文
Editas Medicine· @editasmed · X·· 14 天前AI 评分20
AI 导读

本周日,Editas Medicine 将在芝加哥举行的今年美国心脏协会科学年会上,展示其领先的体内开发候选药物 EDIT-401 的新临床前数据。详情请见:https://bit.ly/3W4FGTL。 #AHA2026 #invivo #geneediting

正文

This Sunday, Editas Medicine will present new preclinical data on EDIT-401, our lead in vivo development candidate, at this year’s American Heart Association Scientific Sessions in Chicago. For more details, read here: https://bit.ly/3W4FGTL. #AHA2026 #invivo #geneediting

来源:Editas Medicine · x.com